Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)

2024-514054-70-00 Protocol 76712 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 12 Aug 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol 76712

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 14
Countries 1
Sites 1

Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.

Key facts

Sponsor
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
12 Aug 2024 → ongoing
Decision date (initial)
2024-08-12
Transition trial
Yes
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

External identifiers

EU CT number
2024-514054-70-00
EudraCT number
2021-000496-37

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Sponsor organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Address
Dr. Molewaterplein 40
City
Rotterdam
Postcode
3015 GD
Country
Netherlands

Scientific contact point

Organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Contact name
Joachim G.J.V. Aerts

Public contact point

Organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Contact name
Ton Boersma

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 14 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ongoing, recruiting
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Pulmonary Science, Dr. Molewaterplein 40, 3015 GD, Rotterdam

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2024-08-12 2024-08-12

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-07-29 Netherlands Acceptable with conditions
2024-08-12
2024-08-12